A018680 logo

Seoul Pharma Co., Ltd Stock Price

KOSDAQ:A018680 Community·₩31.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A018680 Share Price Performance

₩0
-3085.00 (-100.00%)
₩0
-3085.00 (-100.00%)
Price ₩0

A018680 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with questionable track record.

2 Risks
0 Rewards

Seoul Pharma Co., Ltd Key Details

₩52.1b

Revenue

₩20.6b

Cost of Revenue

₩31.5b

Gross Profit

₩30.7b

Other Expenses

₩753.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
64.64
60.41%
1.45%
36.5%
View Full Analysis

About A018680

Founded
1976
Employees
n/a
CEO
Hei Youn Hwang
WebsiteView website
www.seoulpharma.com

Seoul Pharma Co., Ltd manufactures and sells pharmaceutical products in South Korea and internationally. The company offers orally disintegrating film products for therapeutic areas, including urology, neurology, nutrition, endocrinology, and OB/GY. Its products include VULTEUM and VULTIS for erectile dysfunction; ARTPEZIL for Alzheimer’ disease; OBCARE to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency; and CH.V, as well as products for schizophrenia, vitamin supplement, obesity, tonic, and menopausal syndrome. The company also provides Ator for high blood pressure treatment; Flavel to treat stroke; Axated, a peptic ulcer medication; Crestin to treat hyperlipidemia; and Weltmin and Fendigene for the treatment of obesity. It also owns patents to orally dispersible films. The company was founded in 1976 and is headquartered in Cheongju-si, South Korea.

Recent A018680 News & Updates

Recent updates

No updates